Stock Information
Ocular Therapeutix Inc (OCUL)
Ticker Symbol: OCUL
Exchange: NASDAQ
Sector: Pharmaceuticals
Market Cap: $1,808.77 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -1.4385
Revenue (TTM): $0.23 M
Dividend Yield: N/A%
ROE: -71.66%
Latest News
-
Ocular Therapeutix Reports Inducement Grants under Nasdaq Listing Rule 5635(4)
Wed, Apr 15, 2026 9:44 AM
-
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Tue, Apr 14, 2026 7:01 AM
-
Ocular Therapeutix Inc Announces Additional Positive Week 52 Data from Landmark SOL-1 Phase 3 Trial of AXPAXLI in Wet AMD
Mon, Apr 13, 2026 3:08 PM
-
Ocular's Axpaxli Cuts Risk Of Worsening In Late-Stage AMD Study
Mon, Apr 13, 2026 1:31 PM
-
HC Wainwright & Co. Reiterates Buy on Ocular Therapeutix, Maintains $21 Price Target
Mon, Apr 13, 2026 12:59 PM
-
Ocular Therapeutix Reports One-Year Results For Eye Disease Treatment
Mon, Apr 13, 2026 7:08 AM
-
Ocular Therapeutix™ Announces Additional Positive Week 52 Data from Landmark SOL-1 Phase 3 Trial of AXPAXLI™ in Wet AMD
Mon, Apr 13, 2026 7:01 AM
Key Financials
Financial data not available
